Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Novartis Ag Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $44,779 - $50,776	-484 Reduced 24.4%	1,500 $151,000
Q1 2023 May 17, 2024	BUY	$80.03 - $92.81 $38,734 - $44,920	484 Added 32.27%	1,984 $182,000
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $38,734 - $44,920	484 Added 32.27%	1,984 $182,000
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $46,387 - $56,807	-614 Reduced 29.04%	1,500 $136,000
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $45,810 - $53,577	614 Added 40.93%	2,114 $160,000
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $120,165 - $135,930	1,500 New	1,500 $131,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $119,550 - $132,195	-1,500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $126,524 - $143,055	1,500 New	1,500 $142,000

Others Institutions Holding NVS

# of Institutions

1,423

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account